These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1512984)

  • 1. [Malignant hypertension].
    Ueno Y; Wanaka Y
    Nihon Rinsho; 1992 May; 50 Suppl():459-65. PubMed ID: 1512984
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant hypertension in chronic bilateral kidney diseases].
    Suchecki T; Jankowski B; Rutkowski B; Szczerba A; Stolarczyk J; Manitius A
    Kardiol Pol; 1980; 23(1):83-8. PubMed ID: 7366076
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodialysis therapy of malignant hypertension].
    Takagi N; Ishii M
    Nihon Rinsho; 1992 Jan; 50 Suppl():164-70. PubMed ID: 1349656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathophysiology and prognosis in malignant hypertension: comparison by underlying diseases].
    Kawazoe N
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):467-76. PubMed ID: 2515135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hypertension - the role of the paracrine renin-angiotensin system.
    Fleming S
    J Pathol; 2000 Oct; 192(2):135-9. PubMed ID: 11004688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Malignant" intradialytic hypertension: a severe form of intradialytic hypertension.
    Fourtounas C
    Am J Kidney Dis; 2010 Aug; 56(2):418; author reply 418-9. PubMed ID: 20659627
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of malignant hypertension with an angiotensin converting enzyme inhibitor.
    Cottone S; Mangano MT; Fulantelli MA; Cerasola G; Salerno L; Nardi E; Lodato G; Traina C
    Clin Ther; 1989; 11(4):511-20. PubMed ID: 2550135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scleroderma renal crisis (SRC): hypertensive, normotensive].
    Endo H
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):656-60. PubMed ID: 11210764
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism and treatment of malignant hypertension.
    Pérez-Grovas H; Herrera-Acosta J
    Semin Nephrol; 1988 Jun; 8(2):147-54. PubMed ID: 3293138
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hypertension in HIV-associated glomerulonephritis.
    Morales E; Gutierrez-Solis E; Gutierrez E; González R; Martínez MA; Praga M
    Nephrol Dial Transplant; 2008 Dec; 23(12):3901-7. PubMed ID: 18647741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of excessive hypertension in patients with terminal renal failure by intermittent hemodialysis and bilateral nephrectomy.
    Keynan A; Aviram A; Czaczkes JW; Ullmann TD
    Isr J Med Sci; 1969; 5(3):400-6. PubMed ID: 5821825
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical treatment of malignant hypertension. Physiopathological basis and results of treatment with sympatholytic drugs, heparin and dipyridamole].
    Coratelli P; Campese VM; Amerio A
    Minerva Nefrol; 1974; 21(4):324-33. PubMed ID: 4467053
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal crisis in scleroderma].
    Fagel WJ; van Es LA
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2588-90. PubMed ID: 1480244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant arterial hypertension--clinical picture, prognosis, management].
    Makowiecka-Cieśla M
    Przegl Lek; 1994; 51(1):29-35. PubMed ID: 8208993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant or accelerated hypertension.
    Vaziri ND
    West J Med; 1984 Apr; 140(4):575-82. PubMed ID: 6372248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant hypertension].
    Rymaszewski Z; Uchman B
    Kardiol Pol; 1981; 24(10):703-8. PubMed ID: 7329008
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term prognosis of malignant hypertension; difference between underlying diseases such as essential hypertension and chronic glomerulonephritis.
    Kawazoe N; Eto T; Abe I; Takishita S; Ueno M; Kobayashi K; Uezono K; Muratani H; Kimura Y; Tomita Y
    Clin Nephrol; 1988 Feb; 29(2):53-7. PubMed ID: 3359695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant arterial hypertension. Clinical aspects and prognostic factors in 165 cases (1974-1984)].
    Martínez-Amenós A; Carratalá J; Pintó X; Romero M; Santaló M; Serón D; Virgili N; Alsina J
    Med Clin (Barc); 1987 May; 88(17):661-5. PubMed ID: 2956469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of certain factors in prognosis of the course of malignant hypertension in terminal stage of chronic renal insufficiency and the problems of therapeutic tactics].
    Shraer TI; Torgunakov AP; Gorbunov VV; Osipov LE
    Urol Nefrol (Mosk); 1976; (2):18-22. PubMed ID: 982716
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of aldosterone in experimental hypertension.
    McCaa RE; McCaa CS; Bengis RG; Guyton AC
    J Endocrinol; 1979 May; 81(2):69P-78P. PubMed ID: 222873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.